Evidence map›Paper›PMID 34386097›Full record

ArticleEFSA journal. European Food Safety Authority2021

Guidance on aneugenicity assessment.

EFSA Scientific Committee (SC), Simon John More, Vasileios Bampidis, Claude Bragard, Thorhallur Ingi Halldorsson, Antonio F Hernández-Jerez, Susanne Hougaard Bennekou, Kostas Koutsoumanis, Claude Lambré, Kyriaki Machera and 20 more

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Application of chimeric mice with human hepatocytes for the evaluation of metabolically activated genotoxic substances.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Peer review of the pesticide risk assessment of the active substance ziram.EFSA journal. European Food Safety Authority · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Critical Evaluation of Methods for the Identification of Aneugens.Environmental and molecular mutagenesis · 2025
    Review
  15. Re-evaluation of neotame (E 961) as food additive.EFSA journal. European Food Safety Authority · 2025
    Article
  16. Assessment of the feed additive consisting of a strain belonging toEFSA journal. European Food Safety Authority · 2025
    Article
  17. Article
  18. Risk assessment of food contact materials.EFSA journal. European Food Safety Authority · 2024
    Article
  19. Exploring the role of oxidative stress and mitochondrial dysfunction in β-damascone-induced aneuploidy.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

EFSA Scientific Committee (SC)
Simon John More
Vasileios Bampidis
Claude Bragard
Thorhallur Ingi Halldorsson
Antonio F Hernández-Jerez
Susanne Hougaard Bennekou
Kostas Koutsoumanis
Claude Lambré
Kyriaki Machera
Hanspeter Naegeli
Søren Saxmose Nielsen
Josef Schlatter
Dieter Schrenk
Dominique Turck
Maged Younes
Gabriele Aquilina
Margherita Bignami
Claudia Bolognesi
Riccardo Crebelli
Rainer Gürtler
Francesca Marcon
Elsa Nielsen
Christiane Vleminckx
Maria Carfì
Carla Martino
Daniela Maurici
Juan Parra Morte
Annamaria Rossi
Diane Benford

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The EFSA Scientific Committee was asked to provide guidance on the most appropriate

Indexed as

aneugenicitygenotoxicity in vivo and in vitromicronucleus test

Identifiers

PMID34386097
PMCPMC8340060

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.